Doximity (DOCS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Individual investo ...

Company Performance - Doximity's stock (DOCS) decreased by 1.44% to $59.38, underperforming the S&P 500's daily gain of 0.06% [1] - Over the past month, Doximity's stock has increased by 3.92%, while the Medical sector has declined by 1.83% and the S&P 500 has risen by 5.88% [1] Earnings Forecast - Doximity is expected to release its earnings on August 7, 2025, with a forecasted EPS of $0.31, reflecting a 10.71% increase from the same quarter last year [2] - Revenue is projected to be $139.67 million, indicating a 10.26% growth compared to the corresponding quarter of the previous year [2] Full-Year Estimates - The Zacks Consensus Estimates for Doximity's full-year earnings are $1.46 per share and revenue of $625.72 million, representing year-over-year changes of +2.82% and +9.7%, respectively [3] - Recent adjustments to analyst estimates suggest evolving short-term business trends, with positive revisions indicating analyst optimism [3] Valuation Metrics - Doximity has a Forward P/E ratio of 41.3, which is higher than the industry average of 28.27 [6] - The company also has a PEG ratio of 4.48, compared to the Medical Info Systems industry's average PEG ratio of 3.23 [6] Industry Ranking - The Medical Info Systems industry, part of the Medical sector, holds a Zacks Industry Rank of 81, placing it in the top 33% of over 250 industries [7] - The Zacks Industry Rank is based on the average Zacks Rank of individual stocks within the industry, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [7]

Company Performance - Doximity (DOCS) closed at $61.09, with a +1.13% change from the previous day, outperforming the S&P 500's gain of 0.52% [1] - The stock has increased by 16.31% over the past month, significantly surpassing the Medical sector's gain of 3.5% and the S&P 500's gain of 5.95% [1] Upcoming Earnings Report - Doximity is expected to report an EPS of $0.31, reflecting a 10.71% increase from the same quarter last year [2] - Revenue is forecasted at $139.67 million, indicating a 10.26% rise compared to the same quarter last year [2] Full Year Projections - For the full year, earnings are projected at $1.46 per share, with a revenue estimate of $625.72 million, showing increases of +2.82% and +9.7% respectively from the previous year [3] Analyst Estimates and Confidence - Recent changes in analyst estimates for Doximity are important as they reflect near-term business trends, with positive revisions indicating analysts' confidence in the company's performance [3][4] Zacks Rank and Performance - Doximity currently holds a Zacks Rank of 3 (Hold), with a consensus EPS projection that has increased by 0.5% in the past 30 days [5] - The Zacks Rank system has a proven track record of outperformance, with 1 stocks returning an average of +25% annually since 1988 [5] Valuation Metrics - Doximity has a Forward P/E ratio of 41.41, which is a premium compared to the industry average Forward P/E of 32.04 [6] - The company has a PEG ratio of 4.49, higher than the industry average PEG ratio of 2.75 [7] Industry Ranking - The Medical Info Systems industry, to which Doximity belongs, ranks in the top 31% of all industries, with a current Zacks Industry Rank of 74 [7]